|
1.
|
Katzman M. A piece of my mind. The clock doctor. JAMA. 2013 Apr 3; 309(13):1357-8.
|
|
|
|
|
2.
|
Ealy JB, Sudol M, Krzeminski J, Amin S, Katzman M. Alternative nucleophilic substrates for the endonuclease activities of human immunodeficiency virus type 1 integrase. Virology. 2012 Nov 10; 433(1):149-56.
|
|
|
|
|
3.
|
Sudol M, Fritz JL, Tran M, Robertson GP, Ealy JB, Katzman M. Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds. Antivir Chem Chemother. 2011; 22(2):67-74.
|
|
|
|
|
4.
|
Sudol M, Tran M, Nowak MG, Flanagan JM, Robertson GP, Katzman M. A nonradioactive plate-based assay for stimulators of nonspecific DNA nicking by HIV-1 integrase and other nucleases. Anal Biochem. 2010 Jan 15; 396(2):223-30.
|
|
|
|
|
5.
|
Nowak MG, Sudol M, Lee NE, Konsavage WM, Katzman M. Identifying amino acid residues that contribute to the cellular-DNA binding site on retroviral integrase. Virology. 2009 Jun 20; 389(1-2):141-8.
|
|
|
|
|
6.
|
Konsavage WM, Sudol M, Katzman M. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase. Virology. 2008 Sep 30; 379(2):223-33.
|
|
|
|
|
7.
|
Konsavage WM, Sudol M, Lee NE, Katzman M. Retroviral integrases that are improved for processing but impaired for joining. Virus Res. 2007 May; 125(2):198-210.
|
|
|
|
|
8.
|
Konsavage WM, Burkholder S, Sudol M, Harper AL, Katzman M. A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities. J Virol. 2005 Apr; 79(8):4691-9.
|
|
|
|
|
9.
|
Harper AL, Sudol M, Katzman M. An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J Virol. 2003 Mar; 77(6):3838-45.
|
|
|
|
|
10.
|
Katzman M, Harper AL, Sudol M, Skinner LM, Eyster ME. Activity of HIV-1 integrases recovered from subjects with varied rates of disease progression. J Acquir Immune Defic Syndr. 2001 Nov 1; 28(3):203-10.
|
|
|
|
|
11.
|
Harper AL, Skinner LM, Sudol M, Katzman M. Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection. J Virol. 2001 Aug; 75(16):7756-62.
|
|
|
|
|
12.
|
Skinner LM, Sudol M, Harper AL, Katzman M. Nucleophile selection for the endonuclease activities of human, ovine, and avian retroviral integrases. J Biol Chem. 2001 Jan 5; 276(1):114-24.
|
|
|
|
|
13.
|
Morgan AL, Katzman M. Subterminal viral DNA nucleotides as specific recognition signals for human immunodeficiency virus type 1 and visna virus integrases under magnesium-dependent conditions. J Gen Virol. 2000 Mar; 81(Pt 3):839-49.
|
|
|
|
|
14.
|
Katzman M, Sudol M, Pufnock JS, Zeto S, Skinner LM. Mapping target site selection for the non-specific nuclease activities of retroviral integrase. Virus Res. 2000 Jan; 66(1):87-100.
|
|
|
|
|
15.
|
Katzman M, Katz RA. Substrate recognition by retroviral integrases. Adv Virus Res. 1999; 52:371-95.
|
|
|
|
|
16.
|
Skinner LM, Lamers SL, Sanders JC, Eyster ME, Goodenow MM, Katzman M. Analysis of a large collection of natural HIV-1 integrase sequences, including those from long-term nonprogressors. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1; 19(2):99-110.
|
|
|
|
|
17.
|
Katzman M, Sudol M. Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins. J Virol. 1998 Mar; 72(3):1744-53.
|
|
|
|
|
18.
|
Katzman M, Sudol M. Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases. J Virol. 1996 Dec; 70(12):9069-73.
|
|
|
|
|
19.
|
Katzman M, Sudol M. Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases. J Virol. 1996 Apr; 70(4):2598-604.
|
|
|
|
|
20.
|
Katzman M, Sudol M. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases. J Virol. 1995 Sep; 69(9):5687-96.
|
|
|
|
|
21.
|
Fiscus SA, DeGruttola V, Gupta P, Katzenstein DA, Meyer WA, LoFaro ML, Katzman M, Ragni MV, Reichelderfer PS, Coombs RW. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial. J Infect Dis. 1995 Feb; 171(2):305-11.
|
|
|
|
|
22.
|
Katzman M, Sudol M. In vitro activities of purified visna virus integrase. J Virol. 1994 Jun; 68(6):3558-69.
|
|
|
|
|
23.
|
Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, Ragni MV, Meyer WA, Gupta P, Rasheed S, Coombs R, et al. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis. 1994 Apr; 169(4):722-9.
|
|
|
|
|
24.
|
Katzman M. Use of oil overlays in "oil-free" PCR technology. Biotechniques. 1993 Jan; 14(1):36-40.
|
|
|
|
|
25.
|
O'Bryan TA, Whitener CJ, Katzman M, Appelbaum PC. Hepatobiliary infections caused by Haemophilus species. Clin Infect Dis. 1992 Oct; 15(4):716-9.
|
|
|
|
|
26.
|
Cobrinik D, Aiyar A, Ge Z, Katzman M, Huang H, Leis J. Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J Virol. 1991 Jul; 65(7):3864-72.
|
|
|
|
|
27.
|
Katzman M, Mack JP, Skalka AM, Leis J. A covalent complex between retroviral integrase and nicked substrate DNA. Proc Natl Acad Sci U S A. 1991 Jun 1; 88(11):4695-9.
|
|
|
|
|
28.
|
Katzman M, Katz RA, Skalka AM, Leis J. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol. 1989 Dec; 63(12):5319-27.
|
|
|
|
|
29.
|
Wiest PM, Flanigan T, Salata RA, Shlaes DM, Katzman M, Lederman MM. Serious infectious complications of corticosteroid therapy for COPD. Chest. 1989 Jun; 95(6):1180-4.
|
|
|
|
|
30.
|
Terry R, Soltis DA, Katzman M, Cobrinik D, Leis J, Skalka AM. Properties of avian sarcoma-leukosis virus pp32-related pol-endonucleases produced in Escherichia coli. J Virol. 1988 Jul; 62(7):2358-65.
|
|
|
|
|
31.
|
Kaminski HJ, Katzman M, Wiest PM, Ellner JJ, Gifford DR, Rackley R, Iskandar SS, Lederman MM. Cardiomyopathy associated with the acquired immune deficiency syndrome. J Acquir Immune Defic Syndr. 1988; 1(2):105-10.
|
|
|
|
|
32.
|
Katzman M, Lederman MM, Spagnuolo PJ. Fibronectin and cellular cytotoxicity: evidence against a role for fibronectin in natural killer activity. J Lab Clin Med. 1987 Jul; 110(1):75-82.
|
|
|
|
|
33.
|
Katzman M, Carey JT, Elmets CA, Jacobs GH, Lederman MM. Molluscum contagiosum and the acquired immunodeficiency syndrome: clinical and immunological details of two cases. Br J Dermatol. 1987 Jan; 116(1):131-8.
|
|
|
|
|
34.
|
Katzman M, Lederman MM. Defective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacs. J Clin Invest. 1986 Apr; 77(4):1057-62.
|
|
|
|
|
35.
|
Katzman M, Elmets CA, Lederman MM. Molluscum contagiosum and the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Mar; 102(3):413-4.
|
|
|
|